Skip to main content

Table 3 Sensitivity, specificity, and diagnostic accuracy of serum bile acids levels to distinguish viral hepatitis from NAFLD

From: The role of serum bile acid profile in differentiation between nonalcoholic fatty liver disease and chronic viral hepatitis

Viral hepatitis (group 2) versus NAFLD (group 3)
  AUC p 95% C.I Cutoff Sensitivity Specificity PPV NPV
TCA 0.749* < 0.001* 0.68–0.81 > 0.001 54.11 92.31 96.3 35.0
TCDCA 0.627* 0.003* 0.55–0.70 > 0.02 60.96 56.41 84.0 27.8
TUDCA 0.608* 0.006* 0.55–0.70 > 0 59.59 43.59 79.8 22.4
TLCA 0.575 0.108 0.50–0.65 > 0 66.44 43.59 81.5 25.8
GCA 0.657 0.006* 0.58–0.73 > 0.35 51.37 64.10 84.3 26.0
GCDCA 0.667 0.001* 0.59–0.73 > 1.1 50.0 76.92 89.0 29.1
UDCA 0.570 0.182 0.45–0.69 > 0 75.34 51.28 85.3 35.7
DCA 0.602 0.049* 0.49–0.71 > 0.04 81.51 43.59 84.4 38.6
LCA 0.769 < 0.001* 0.70–0.83 > 0 58.22 92.31 96.6 37.1
  1. AUC area under a curve, p value probability value, CI confidence intervals, NPV negative predictive value, PPV positive predictive value, CDCA chenodeoxycholic acid, TCA taurocholic acid, TCDCA taurochenodeoxycholic acid, TUDCA taurodeoxycholic acid, TLCA taurolithocholic acid, GCA glycholic acid, GCDCA glycochenodeoxycholic acid, UDCA ursodeoxycholic acid, DCA deoxycholic acid, LCA lithocholic acid
  2. *Statistically significant at p < 0.05